Product releases by leading market competitors are projected to fuel the worldwide electrophysiological devices market growth throughout the forecast period. Throughout the projected period, the worldwide electrophysiological devices market is likely to be driven by increasing adoption of inorganic growth tactics such as product clearance by regulatory organisations such as the United States Food and Drug Administration. For example, in July 2020, Abbott, a medical device firm, reported that the Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) device had obtained FDA clearance. Throughout the projection period, the market is likely to be hampered by an increase in product recalls by regulatory bodies such as the United States Food and Drug Administration.
According to Coherent Market Insights, the global Electrophysiology Devices Market is estimated to be valued at US$ 7,756.5 million in 2022 and is expected to exhibit a CAGR of 12.6% during the forecast period (2022-2030).
Top Companies in the Electrophysiology Devices Industry:
General Electric Company
General Electric Company operates as a high-tech industrial company in Europe, China, Asia, the Americas, the Middle East, and Africa. It offers gas and steam turbines, full balance of plant, upgrade, and service solutions, as well as data-leveraging software for power generation, industrial, government, and other customers. General Electric Company was incorporated in 1892 and is headquartered in Boston, Massachusetts.
Biotricity
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California. Founded in 2014. On December 12, 2022 Biotricity, Inc. announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.
Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. The company was founded in 1949 and is headquartered in Dublin, Ireland.